細胞治療技術市場：製品、プロセス、細胞タイプ、エンドユーザー別-2024-2030年の世界予測

細胞治療技術市場規模は2023年に194億8,000万米ドルと推定され、2024年には223億1,000万米ドルに達し、CAGR 14.63％で2030年には506億9,000万米ドルに達すると予測されます。

細胞治療技術市場には、治療目的の細胞療法の研究開発、生産、応用に使用される製品、サービス、技術が含まれます。これには、消耗品（試薬、酵素、培地）、機器（インキュベーター、遠心分離機）、サービス（細胞治療製造）といった幅広い製品が含まれます。この分野は主に、様々な疾患や障害を治療するために、損傷した組織や細胞の修復や置換に焦点を当てた再生医療や免疫療法の進歩によって牽引されています。細胞治療技術は、腫瘍学、心血管疾患治療、整形外科治療、自己免疫疾患管理、遺伝性遺伝性疾患修正など、複数の分野で応用されています。がん、糖尿病、心血管疾患などの慢性疾患の世界の負担の増大は、革新的な治療法に対する需要を加速させています。加えて、政府機関や民間投資家からの有利な資金調達シナリオにより、細胞治療開発に関連する研究活動への投資が増加しています。しかし、細胞治療の開発と生産には複雑な手順が必要な場合が多く、その結果、関連コストが高くなり、手頃な価格と入手しやすさが制限されます。熟練労働者の不足は、業界内の進歩の速度に影響を与える可能性があります。このような課題を克服するため、バイオ医薬品企業と研究機関の戦略的提携が急速に拡大しています。人工知能（AI）や機械学習（ML）を活用してプロセスを最適化したり、細胞治療の新たな標的を特定したり、3Dバイオプリンティングを活用したりすることで、業界のすそ野はさらに広がる可能性があります。

製品ビッグデータ分析ツールの登場が細胞治療用ソフトウェアツールの採用を促進

消耗品は、細胞の分離、拡大、分化、保存など、細胞治療の様々な段階で必要とされる重要なコンポーネントです。主な消耗品には、試薬、培地、血清、成長因子、その他細胞の最適な増殖条件を維持するために必要なサプリメントなどが含まれます。細胞治療技術で使用される機器には、患者に投与する前に細胞を分離、精製、拡大、分化、遺伝子組換えするための機器が含まれます。このカテゴリーには、バイオリアクター（シングルユースまたは再利用可能）、遠心分離機（密度に基づいて細胞を分離するため）、フローサイトメーター（異なるタイプの細胞を同定するため）が含まれます。細胞治療用の消耗品や機器は、科学者が薬剤開発の目的で培養液中で新しい細胞を増殖させることを可能にします。ソフトウェア・ソリューションは、細胞治療中に生成されるデータの効果的な管理、分析、解釈に不可欠です。これらのソフトウェア・ツールは、品質管理パラメータのモニタリング、データ解析、治療結果の予測を支援します。

プロセス細胞保存技術の進歩

細胞の保存は、保存中や輸送中の細胞の生存能力や機能性を維持するために不可欠です。保存方法（凍結保存やガラス化など）や培地の選択は、細胞の種類や用途によって異なります。細胞処理には、骨髄や脂肪組織など様々な供給源から治療用細胞を分離、修飾、濃縮することが含まれます。この段階は、移植後の副作用を最小限に抑えながら、望ましい治療効果を達成するために極めて重要です。プロセス・モニタリングは、細胞ベースの治療法の規制要件を満たすために、製造プロセス全体を通して重要な品質特性が維持されていることを保証します。品質管理は、最終的な治療製品を評価し、その安全性、有効性、純度を保証するために極めて重要です。

細胞の種類細胞・遺伝子治療におけるヒト細胞の利用拡大

動物細胞は、創薬、疾患モデリング、毒性学研究、基礎科学研究など、様々な研究分野で広く利用されています。動物細胞は、細胞プロセスを研究し、複雑な生物学的システムを理解するための貴重なツールとして役立っています。さらに動物細胞は、治療薬のための組換えタンパク質を生産するバイオプロセスにおいても重要な役割を果たしています。治療におけるヒト細胞の使用は、幹細胞研究や再生医療の進歩により著しく増加しています。ヒト由来細胞は、独自の遺伝子構成に基づく特定の患者プロファイルを標的とすることで、疾患の治療や予防を目指す個別化医療アプローチにとって不可欠なツールとなっています。

エンドユーザー研究機関への投資を促進する政府の取り組み

ヘルスケアおよびライフサイエンス分野では、個別化医療、再生医療、患者の予後改善への継続的な取り組みなどの要因により、細胞治療技術に対するニーズが高まっています。これらの技術には、細胞の分離、拡大、分析、保管、輸送に使用される高度な機器や消耗品が含まれます。ヘルスケアおよびライフサイエンス機関のニーズに基づく嗜好は、臨床グレードの試薬から、高品質な基準を維持しながら迅速な細胞増殖を促進する効率的な細胞培養システムまで多岐にわたる。研究機関は主に、細胞プロセスの理解、新たな治療ターゲットの特定、細胞治療技術を用いた疾患治療のための革新的なアプローチの開発に重点を置いています。彼らのニーズには、様々な条件下での細胞の挙動に関する正確な洞察を提供する最先端の分析ツールやデジタルツールが含まれます。

地域別の洞察

米国とカナダは、南北アメリカにおける細胞治療技術の成長に大きく貢献しています。確立されたバイオテクノロジーと製薬産業が存在し、多くの研究機関がこの分野のイノベーションを促進しています。米国は細胞治療のイノベーションに関する特許出願件数でリードしており、これが民間および公的機関からの投資を促しています。さらに、腫瘍学や遺伝性疾患の研究を推進するための政府のイニシアティブや資金援助が、遺伝子治療や細胞治療技術の開発を加速させています。欧州では、研究開発に力を入れている欧州連合（EU）諸国が細胞治療技術市場をリードしています。欧州のバイオテクノロジー企業数社は、先進治療薬（ATMP）の臨床試験で大きな成果を上げています。アジア太平洋地域では、中国、日本、インドが細胞治療技術の急成長市場です。中国は、細胞治療に特化したバイオテクノロジー企業への多額の投資により、主要プレーヤーとしての地位を確立しています。中国の規制改革は臨床試験の承認プロセスを迅速化し、細胞治療の迅速な商業化を可能にしています。日本が再生医療研究でリードしているのは、主に政府がこの分野を積極的に支援しているためです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは細胞治療技術市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、細胞治療技術市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.細胞治療技術市場の市場規模および予測は？

2.細胞治療技術市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.細胞治療技術市場の技術動向と規制枠組みは？

4.細胞治療技術市場における主要ベンダーの市場シェアは？

5.細胞治療技術市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や感染症の発生が世界中で増加
    • 細胞治療製造施設のGMP認証の増加
    • 細胞ベースの調査への投資による政府の取り組みの急増
  • 抑制要因
    • 細胞治療技術に関連する高コスト
  • 機会
    • 個別化医療への継続的な注力
    • 技術におけるES細胞の代替としてのiPSCの出現
  • 課題
    • 熟練した専門家の不足と厳しい規制枠組み
• 市場セグメンテーション分析
  • 製品：ビッグデータ分析ツールの登場により、細胞治療用ソフトウェアツールの採用が促進される
  • プロセス：細胞保存技術の進歩
  • 細胞の種類：細胞および遺伝子治療におけるヒト細胞の利用の増加
  • エンドユーザー：調査機関への投資を促進する政府の取り組み
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 細胞治療技術市場：製品別

• 消耗品
• 装置
• ソフトウェア

第7章 細胞治療技術市場：プロセス別

• 細胞の保存、配布、取り扱い
• 細胞処理
• プロセス監視と品質管理

第8章 細胞治療技術市場細胞の種類別

• 動物細胞
• ヒト細胞

第9章 細胞治療技術市場：エンドユーザー別

• ヘルスケアとライフサイエンス
• 調査機関

第10章 南北アメリカの細胞治療技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の細胞治療技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞治療技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • Clade Therapeutics、Gadeta B.V.の買収を発表
  • スタートアップ企業セラレス、投資家が細胞治療生産に資金を投入し2億5,500万米ドルを追加
  • NewBiologix、遺伝子・細胞治療の製造に向けた新技術プラットフォームの推進に向け、5,000万米ドルを調達して設立
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
• FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
• FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 88. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 89. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 90. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 91. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 92. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 93. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 94. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 95. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 128. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 137. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 140. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 141. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 142. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 145. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 146. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 152. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 153. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 154. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 155. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 156. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 157. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 158. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 159. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 162. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 163. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 164. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 165. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 166. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 167. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 168. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 169. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 170. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 171. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 172. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 173. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 176. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 177. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 178. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 181. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 182. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 183. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 188. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 189. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 190. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 191. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 192. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 193. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 194. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 195. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 196. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 197. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 200. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 201. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 202. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 203. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 204. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 205. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 206. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 207. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 212. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 213. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 214. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 215. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 216. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 217. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 218. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 219. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 222. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 223. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 224. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 225. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 226. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 227. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 228. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 229. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 230. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 231. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 232. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 233. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 234. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 236. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 238. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 240. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 248. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 249. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 250. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 251. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 252. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 253. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 254. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 255. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 258. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 259. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 260. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 261. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 262. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 263. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 264. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 265. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 266. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 267. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 270. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 271. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 272. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 273. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 274. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 275. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 276. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 277. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 278. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 279. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 280. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 281. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 282. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 295. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 296. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 297. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 298. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 299. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 300. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 301. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 302. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 303. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 304. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 305. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 306. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 307. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 310. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 311. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 312. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 313. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 314. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 315. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 316. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 317. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 318. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 319. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 320. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 321. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 322. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 323. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 324. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 325. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 326. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 327. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 328. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 329. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 330. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 331. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 332. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 333. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 334. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)

TABLE 33

[188 Pages Report] The Cell Therapy Technologies Market size was estimated at USD 19.48 billion in 2023 and expected to reach USD 22.31 billion in 2024, at a CAGR 14.63% to reach USD 50.69 billion by 2030.

The cell therapy technologies market encompasses the products, services, and techniques employed in the research, development, production, and application of cellular therapies for therapeutic purposes. This includes a wide range of products such as consumables (reagents, enzymes, media), equipment (incubators, centrifuges), and services (cell therapy manufacturing). The field is primarily driven by advancements in regenerative medicine and immunotherapies that focus on repairing or replacing damaged tissue or cells to treat various diseases and disorders. Cell therapy technologies find applications in multiple areas such as oncology, cardiovascular disease treatment, orthopedic treatments, autoimmune disorders management, and inherited genetic disorders correction. The increasing global burden of chronic diseases such cancer, diabetes and cardiovascular disorders has accelerated the demand for innovative therapies. Additionally, favorable funding scenarios from government agencies and private investors have led to increased investments in research activities related to cell therapy development. However, the development and production of cell therapies often require complex procedures, which result in high associated costs, limiting their affordability and accessibility. A dearth of skilled workers may affect the rate at which advancements are made within the industry. Strategic alliances among biopharmaceutical companies and research institutes are rapidly expanding to overcome such challenges. Leveraging artificial intelligence (AI) and machine learning (ML) to optimize processes or identify new targets for cellular therapies and utilization of 3D bioprinting can further expand the scope of the industry.

Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies

Consumables are essential components required during the various stages of cell therapy procedures, such as cell isolation, expansion, differentiation, and preservation. Key consumables include reagents, media, sera, growth factors, and other supplements needed to maintain optimal cell growth conditions. Equipment used in cell therapy technologies includes devices for isolation, purification, expansion, differentiation, or genetic modification of cells before administering them to patients. This category comprises bioreactors (single-use or reusable), centrifuges (for separating cells based on density), and flow cytometers (for identifying different types of cells). Cell therapy consumables and equipment enable scientists to grow new cells in the culture media for the purpose of drug development. Software solutions are critical to the effective management, analysis, and interpretation of data generated during cell therapy procedures. These software tools assist in monitoring quality control parameters, data analysis, and predicting treatment outcomes.

Process: Advancements in cell preservation technologies

Cell preservation is vital for maintaining the viability and functionality of cells during storage and transportation. The selection of preservation methods (such as cryopreservation or vitrification) and media depends on the cell type and intended application. Cell processing involves the isolation, modification, and concentration of therapeutic cells from various sources, such as bone marrow or adipose tissue. This step is crucial for achieving desired therapeutic effects while minimizing adverse reactions post-transplantation. Process monitoring ensures that critical quality attributes are maintained throughout manufacturing processes to meet regulatory requirements for cell-based therapies. Quality control is critical for evaluating the final therapeutic product and ensuring its safety, efficacy, and purity.

Cell type: Rising utilization of human cells in cell and gene therapies

Animal cells are widely used in various research areas, including drug discovery, disease modeling, toxicology studies, and basic science research. They serve as valuable tools in studying cellular processes and understanding complex biological systems. Moreover, animal cells play a significant role in bioprocessing for the production of recombinant proteins for therapeutics. The use of human cells in therapy has increased significantly due to advancements in stem cell research and regenerative medicine. Human-derived cells have become essential tools for personalized medicine approaches that aim to treat or prevent diseases by targeting specific patient profiles based on their unique genetic makeup.

End user: Government initiatives to propel investments in research institutes

In the healthcare and life science sector, the need for cell therapy technologies has been increasing due to factors such as personalized medicine, regenerative medicine, and the ongoing drive to improve patient outcomes. These technologies include advanced equipment and consumables used in cell isolation, expansion, analysis, storage, and transportation. Need-based preferences for healthcare and life science organizations range from clinical-grade reagents to efficient cell culture systems that promote rapid cell growth while maintaining high-quality standards. Research institutes primarily focus on understanding cellular processes, identifying new therapeutic targets, and developing innovative approaches for disease treatment using cell therapy technologies. Their needs include cutting-edge analytical and digital tools that provide accurate insights into cellular behavior under various conditions.

Regional Insights

The United States and Canada are major contributors to the growth of cell therapy technologies in the Americas. The presence of established biotechnology and pharmaceutical industries, along with numerous research institutions, drives innovation in this sector. The U.S. leads in patents filed for cell therapy innovations, which encourages investments from private and public entities. Furthermore, government initiatives and funding to propel research for oncology and genetic diseases have accelerated the development of gene and cell therapy technologies. In Europe, the European Union (EU) countries lead the market for cell therapy technologies with a strong focus on research and development. Several European biotech firms have made significant progress in clinical trials for advanced therapeutic medicinal products (ATMPs). China, Japan, and India are fast-growing markets for cell therapy technologies within the Asia Pacific region. China has established itself as a major player due to its considerable investment in biotech companies focused on cellular therapies. Chinese regulatory reforms have expedited approval processes for clinical trials, enabling rapid commercialization of cell therapies. Japan leads in regenerative medicine research primarily because of its government's proactive support for the sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Consumables
  • Equipment
    • Cell Processing Equipment
    • Single-Use Equipment

• Software

• Process
  • Cell Preservation, Distribution, & Handling
  • Cell Processing
  • Process Monitoring & Quality Control

• Cell Type
  • Animal Cells
  • Human Cells
    • Differentiated Cells
    • Stem Cells
• End-User
  • Healthcare & Life Science
  • Research Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Technologies Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Technologies Market?

4. What is the market share of the leading vendors in the Cell Therapy Technologies Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Technologies Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of chronic diseases and infections globally
    • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
    • 5.1.1.3. Surge in government initiatives through investments in cell-based research
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with cell therapy technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing focus on personalized medicine
    • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
  • 5.2.2. Process: Advancements in cell preservation technologies
  • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
  • 5.2.4. End user: Government initiatives to propel investments in research institutes
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cell Therapy Technologies Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment
• 6.4. Software

7. Cell Therapy Technologies Market, by Process

• 7.1. Introduction
• 7.2. Cell Preservation, Distribution, & Handling
• 7.3. Cell Processing
• 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

• 8.1. Introduction
• 8.2. Animal Cells
• 8.3. Human Cells

9. Cell Therapy Technologies Market, by End-User

• 9.1. Introduction
• 9.2. Healthcare & Life Science
• 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
  • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
  • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio